Mole modifications following controlled ovarian stimulation for assisted reproduction technologies

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 926-9959, Iss. 10, 2015-10 ,pp. : 1913-1917

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients

By Howles C. M.   Saunders H.   Alam V.   Engrand P.    

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 907-918

Informa Healthcare

Access to resources Recommend Favorite

Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction?

By Nawroth Frank   Ludwig Michael  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 375-384

Future Medicine

Access to resources Recommend Favorite

Comparing four ovarian reserve markers – associations with ovarian response and live births after assisted reproduction

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 10, 2015-10 ,pp. : 1056-1063

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparing four ovarian reserve markers – associations with ovarian response and live births after assisted reproduction

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 1-6349, Iss. 10, 2015-10 ,pp. : 1056-1063

John Wiley & Sons Inc

Access to resources Recommend Favorite